Weight-loss drug producer invests $5.3 billion in Indiana
The new investments will enhance Lilly’s capacity to manufacture active pharmaceutical ingredients for its latest type 2 diabetes and obesity medicines.
Eli Lilly announced investing another $5.3 billion in a manufacturing plant in Lebanon, Indiana. It will help company to expand the supply of its highly popular weight loss drug Zepbound, diabetes treatment Mounjaro and other medicines in its pipeline. How will it affect the local economy?
Devina Gupta finds out why electricity prices are gone up in Texas and how the National Collegiate Athletic Association (NCAA), which governs university sports in the US, has reached a deal that could lead to college athletes getting paid.
Featured
-
.
Podcast
-
![]()
World Business Report
The latest business and finance news from around the world, on the Βι¶ΉΤΌΕΔ
Related Content
